Tag: Biological E

Govt Panel Recommends EUA For COVID-19 Vaccines Covovax, Corbevax, Anti-Covid Pill Molnupiravir
Hyderabad-Based Biological E. To Get mRNA Technology From WHO For Covid Vaccines

The Hyderabad-based company on Monday announced that it has been selected as a recipient of mRNA technology.

  • Monday, 04 April 2022
Biological E's Corbevax
Corbevax: Biological E to produce 75 mn doses per month

The Hyderabad-based company, Biological E said these capacities will enable it to deliver 300 million doses as promised to the Government of India. Soon, the company plans to deliver more than one billion additional doses globally.

  • Tuesday, 28 December 2021
COVID-19 Vaccine
Biological E Expects 'Corbevax' Rollout By The End Of November

Biological E, the Hyderabad-based vaccine maker, expects the rollout of its Covid-19 vaccine 'Corbevax' by the end of November and is looking to supply nearly 10 crore doses on the day of its launch

  • Monday, 25 October 2021
Covid Vaccine
Biological E To Get $50 Million From US DFC To Boost Covid Vax Production

Founded in 1953, Biological E claims to be the first private sector biological products company in India.

  • Sunday, 24 October 2021
COVID-19 Vaccine
Biological E seeks nod for phase 3 trial of Corbevax as booster dose

Pharma major Biological E has sought approval from drug regulator Drugs Controller General of India to conduct the phase-3 clinical trial of Covid vaccine Corbevax.

  • Tuesday, 12 October 2021
Covid19 Vaccine
Bio E To Roll Out Covid19 Vaccine In India By August 2021

In a major development, the Government of India has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses for the country. As per reports, these vaccine doses will be manufactured and stockpiled by Biological-E from August to December 2021.

Video Icon
  • Friday, 04 June 2021
Covid-19 Vaccine: Biological E Initiates Clinical Trials Following Approval Of DGCI
Covid-19 Vaccine: Biological E Initiates Clinical Trials Following Approval Of DGCI

Hyderabad: Hyderabad-based vaccines and pharmaceutical company Biological E. Ltd (BE) announced that it has initiated clinical trial of its Covid-19 subunit vaccine candidate in the country on Monday following approval from the Drugs Controller General of India (DGCI). BE collaborated with Dynavax Technologies Corporation (Dynavax), a US-based vaccine focused biopharmaceutical company, and Baylor College of […]

  • Friday, 09 April 2021
Envoys Of 64 Countries Visit COVID-19 Vaccine Makers In Hyderabad
Envoys Of 64 Countries Visit COVID-19 Vaccine Makers In Hyderabad

Hyderabad: Envoys of 64 countries on Wednesday visited the facilities of Bharat Biotech and Biological E, which are developing vaccines for coronavirus. After landing in Hyderabad by a special Air India flight, the Ambassadors and High Commissioners from the countries in Asia, Africa, Europe, North America, South America, and Oceania reached Genome Valley on the […]

  • Thursday, 08 April 2021
scrollToTop